PeterMacd2 wrote: The young punk being interviewed here, Shayne Laidlaw, has been an "analyst "at Hedgeye for only 4 years, has never run a business, nor has he had much life experience worth mentioning::
https://www.wealthminder.com/financial-advisors-stamford-CT/ hayne-laidlaw/363370. So why is he given bandwidth to spread his ignorance? I just had to burst out laughing when he said at the end that he thinks APHA is a candidate for bankruptcy in the next year or two! With half a billion in cash, and profitable?! Clearly, as he said, he "dislikes" Irwin Simon. Oh, but Canopy is not going bust because they have 1 billion in the bank. And CRON is a winner because of CBD - obviously forgetting about APHA's ECoE coming online soon. Contemptible.
"Analysts", to me, are like a school of fish. Ever seen a school of fish? - they turn this way, that way, and back again, always in lock-step, you can't know what guides their movement, it's just how they aimlessly spend their time. But if you're interested in analysts' opinions, 9 out of 12 still rate APHA a buy with a median 12 month forecast of CAD $14. (range $7-$26).
https://ca.investing.com/equities/aphria-inc-consensus-estimates. Personally, my 3 year estimate is $30 ($25-35); this assumes Diamond and the ECoC come online this quarter, and the EU business takes off as I think it will. JMO.